Related Experiment Video
Updated: Mar 28, 2026

Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers
Published on: October 17, 2013
Drug Transporters and Multiple Drug Resistance in Pediatric Solid Tumors
Doriana Fruci, William C S Cho1, Valerio Nobili
1Department of Clinical Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong. williamcscho@gmail.com.
Abstract:
Solid tumors account for approximately 30% of all childhood cancers. Although chemotherapy has largely contributed to strongly improve the outcome of children with cancer, multidrug resistance (MDR) remains a major mechanism limiting the overall survival of patients. An increased efflux rate of the anti-neoplastic drugs from cancer cells by action of members of the ATP-binding cassette (ABC) transporters is one of the most important mechanisms of MDR. These drug transporters play a pivotal role in preserving the balance between sensitivity and resistance to anti-neoplastic drug in specific tumor cells. The functional activity of ABC transporters have been extensively studied in adults, but barely investigated in pediatric solid malignancies. Here, we provide evidence from the current literature about MDR and ABC transporters in the most common types of pediatric solid tumors, including neuroblastoma, rhabdomyosarcoma, retinoblastoma, hepatoblastoma and Wilms' tumor.
Insights
Multidrug resistance (MDR) limits childhood cancer survival. This review explores ATP-binding cassette (ABC) transporters
Area of Science:
- Pediatric Oncology
- Cancer Pharmacology
- Molecular Biology
Background:
- Solid tumors represent a significant portion of childhood cancers.
- Chemotherapy has improved outcomes, but multidrug resistance (MDR) remains a challenge.
- ATP-binding cassette (ABC) transporters mediate MDR by increasing drug efflux from cancer cells.
Purpose of the Study:
- To review the current literature on MDR and ABC transporters in common pediatric solid tumors.
- To highlight the limited investigation of ABC transporter function in pediatric malignancies compared to adults.
Main Methods:
- Literature review of existing studies on MDR and ABC transporters.
- Focus on neuroblastoma, rhabdomyosarcoma, retinoblastoma, hepatoblastoma, and Wilms' tumor.
Main Results:
- ABC transporters are key players in MDR across various pediatric solid tumors.
- Evidence suggests differential roles and expression of ABC transporters in these cancers.
- Limited data exists on the functional activity of these transporters in pediatric settings.
Conclusions:
- Understanding ABC transporter roles is crucial for overcoming MDR in pediatric cancers.
- Further research into ABC transporter function in pediatric solid tumors is warranted.
- Targeting ABC transporters may offer novel therapeutic strategies for improving pediatric cancer survival.
More Related Videos
07:10Author Spotlight: Expression and Purification of Human Solute Carrier Transporters Using Codon-Optimized Genes
Published on: September 29, 2023
06:19Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
Published on: June 16, 2023
Related Concept Videos
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Distribution